Rights After Termination. (a) Upon termination or expiration of this AGREEMENT for any reason, LICENSEE shall: (i) promptly pay all amounts due UNIVERSITY through the effective date of the termination (even if they would otherwise be payable at a later date, e.g. within [**] after invoicing), including those in Article III (payments) and Section 7.03 (patent expenses); (ii) submit all final reports under Article IV; and (iii) return any CONFIDENTIAL INFORMATION provided to LICENSEE by UNIVERSITY in connection with this AGREEMENT, or, with UNIVERSITY’s prior approval, destroy such materials, and LICENSEE shall certify in writing that such materials have all been returned or destroyed. (b) Upon termination of this AGREEMENT for any reason, LICENSEE shall: (i) provide UNIVERSITY a copy of any regulatory data or information filed with any U.S. or foreign government agency with respect to the LICENSED PRODUCT; and (ii) shall refrain, and shall require its SUBLICENSEES to refrain unless such sublicense is assigned to UNIVERSITY under Section 10.05, from any further SALES or other commercial exploitation of the LICENSED PRODUCT under this LICENSE AGREEMENT except as provided in Section 10.08. Nothing in this section shall be construed as limiting in any way UNIVERSITY’S rights or remedies that UNIVERSITY may otherwise have, either in law or in equity.
Appears in 3 contracts
Samples: Exclusive License Agreement (Decibel Therapeutics, Inc.), Exclusive License Agreement (Decibel Therapeutics, Inc.), Exclusive License Agreement (Decibel Therapeutics, Inc.)
Rights After Termination. (a) Upon termination or expiration of this AGREEMENT for any reason, LICENSEE shall:
(i) promptly pay all amounts due UNIVERSITY through the effective date of the termination (even if they would otherwise be payable at a later date, e.g. within [**] after invoicing), including those in Article III (payments) and Section 7.03 (patent expenses);
(ii) submit all final reports under Article IV; and
and (iii) return any CONFIDENTIAL INFORMATION provided to LICENSEE by UNIVERSITY in connection with this AGREEMENT, or, with UNIVERSITY’s ’S prior approval, destroy such materials, and LICENSEE shall certify in writing that such materials have all been returned or destroyed.
(b) Upon termination of this AGREEMENT for any reason, LICENSEE shall:
(i) provide UNIVERSITY a copy of any regulatory data or information filed with any U.S. or foreign government agency with respect to the LICENSED PRODUCT; and
(ii) shall refrain, and shall require its SUBLICENSEES to refrain unless such sublicense is assigned to UNIVERSITY under Section 10.05, from any further SALES or other commercial exploitation of the LICENSED PRODUCT under this LICENSE AGREEMENT except as provided in Section 10.08. Nothing in this section shall be construed as limiting in any way UNIVERSITY’S rights or remedies that UNIVERSITY may otherwise have, either in law or in equity.
Appears in 1 contract
Samples: Exclusive License Agreement (Decibel Therapeutics, Inc.)